|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
$0.38 0.00 (0.00%) as of 4:30 Mon 8/21
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
50 |
|
|
|
Total
Direct Shares :
|
16,950,540 |
|
|
Total
Indirect Shares :
|
10,947,999 |
| |
%
Held by Insiders:
|
201.24% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Milano Vincent |
|
2023-08-10 |
8,987 |
2014-12-12 |
0 |
| Salain Daniel |
Chief Operating Officer |
2023-01-17 |
1,469,482 |
2022-09-28 |
0 |
| Taylor John Clayton |
Chief Executive Officer, Director |
2023-01-17 |
1,469,482 |
2022-09-28 |
0 |
| Jordan Andrew R |
Chief Strategy Officer |
2023-01-17 |
451,890 |
2022-09-28 |
0 |
| Dougherty Michael R |
|
2023-01-11 |
375,155 |
2019-10-01 |
0 |
| Lim Bryant David |
|
2023-01-06 |
309,695 |
2018-12-21 |
0 |
| Kirby John J. |
|
2023-01-06 |
316,893 |
2019-01-03 |
0 |
| Wooten Ronald J |
Director |
2022-09-28 |
0 |
2022-09-28 |
5 |
| Nq Pof V Gp, Ltd. |
See Remarks, Director |
2022-09-28 |
5 |
2022-09-28 |
0 |
| Soland Daniel B |
|
2021-06-18 |
78,843 |
|
0 |
| Tarka Elizabeth Ann |
|
2021-03-25 |
13,237 |
2020-01-10 |
0 |
| Geraghty James A |
Director |
2021-01-04 |
104,770 |
2013-08-19 |
0 |
| Schafer Carol |
Director |
2021-01-04 |
48,488 |
2018-12-19 |
0 |
| Goldberg Mark Alan |
Director |
2021-01-04 |
38,099 |
2018-12-19 |
0 |
| Pien Howard H |
Director |
2020-10-01 |
45,457 |
2019-01-02 |
0 |
| Yingling Jonathan Michael |
Chief Scientific Officer |
2020-01-10 |
36,358 |
2019-01-03 |
0 |
| Fletcher Robert C. |
Sr. VP, Bus. Dev. & Strategy |
2020-01-10 |
36,485 |
2019-01-03 |
0 |
| Baker Julian |
10% Owner |
2019-07-01 |
43,858 |
2019-07-01 |
4,290,995 |
| Horobin Joanna |
Chief Medical Officer |
2019-01-03 |
20,144 |
2018-12-20 |
0 |
| Pillar Pharmaceuticals Ii, L.p. |
10% Owner |
2018-07-13 |
0 |
2018-07-20 |
0 |
| Zein Youssef El |
10% Owner |
2017-10-02 |
534,980 |
2023-07-13 |
657,228 |
| Reardon William S |
Director |
2017-07-03 |
32,973 |
2004-07-08 |
0 |
| Gowen Maxine |
|
2017-01-04 |
17,543 |
2023-08-10 |
0 |
| Pillar Pharmaceuticals V Lp |
Director, 10% Owner |
2016-10-07 |
875,000 |
|
0 |
| Casey Mark J |
Senior VP & General Counsel |
2016-05-12 |
34,450 |
2016-05-12 |
0 |
| 667, L.p. |
Director |
2016-04-01 |
0 |
2017-04-03 |
133,666 |
| Maccoss Malcolm |
Director |
2014-07-01 |
3,753 |
2010-10-01 |
0 |
| Baker Bros. Advisors (gp) Llc |
Director |
2014-07-01 |
0 |
2016-01-04 |
78,885 |
| Sullivan Timothy M |
VP Development Programs |
2014-05-27 |
24,914 |
|
0 |
| Abdul-Wahab Umari |
Director |
2014-04-01 |
67,304 |
2014-05-23 |
0 |
| Pillar Invest Corp |
10% Owner |
2014-02-06 |
586,101 |
2018-04-25 |
0 |
| Pillar Pharmaceuticals Iv, L.p. |
Director, 10% Owner |
2013-09-30 |
845,161 |
|
0 |
| Pillar Pharmaceuticals Iii, L.p. |
10% Owner |
2013-05-07 |
2,600,000 |
2018-08-09 |
0 |
| Hartley C Keith |
Director |
2010-11-10 |
54,184 |
2013-05-07 |
92,434 |
| Mueller Hans |
Director |
2009-11-24 |
10,000 |
2009-05-08 |
0 |
| Agrawal Sudhir |
CEO, President & CSO, Director |
2009-06-25 |
126,277 |
2005-03-14 |
0 |
| Wyngaarden James B |
Director |
2008-06-12 |
36,685 |
2003-08-28 |
0 |
| Bexon Alice |
V.P. Clinical Development |
2008-03-14 |
0 |
2008-03-14 |
0 |
| Zamecnik Paul C |
Director Emeritus |
2008-01-02 |
104,622 |
2003-08-28 |
0 |
| Andersen Robert G |
CFO & VP Oper. and Planning |
2007-05-17 |
15,744 |
2004-08-31 |
0 |
| Karr Robert W |
Director |
2005-10-03 |
4,390 |
2013-09-16 |
6,299 |
| Martin Russell |
Senior VP of Drug Development, Chief Medical Officer |
2004-03-15 |
98,750 |
2004-03-15 |
0 |
| Seiler Stephen R |
Chief Executive Officer, Director |
2003-12-05 |
510,000 |
2003-12-05 |
100 |
| Optima Life Science Ltd |
10% Owner |
2003-08-28 |
5,500,381 |
|
0 |
| Chopra Atul |
10% Owner |
|
0 |
2023-05-17 |
1,205,158 |
| Arcudi Louis J. |
|
|
0 |
|
0 |
| Senator Investment Group Lp |
10% Owner |
|
0 |
2012-04-23 |
2,724,700 |
| Baker Brothers Life Sciences Lp |
Director |
|
0 |
2014-03-10 |
1,613,076 |
| Baker Felix |
Director |
|
0 |
2017-07-03 |
145,453 |
| Arbeit Robert D. |
|
|
0 |
|
0 |
|
|
